Stem cell scarring aids recovery from spinal cord injury
In a new study, researchers at Karolinska Institutet in Sweden show that the scar tissue formed by stem cells after a spinal cord injury does not impair recovery; in fact, stem cell scarring confines the damage. The findings, which are published in the scientific journal Science, indicate that scar tissue prevents the lesion from expanding and helps injured nerve cells survive.
Spinal cord injuries sever nerve fibres that conduct signals between the brain and the rest of the body, causing various degrees of paralysis depending on the site and extent of the injury. Functional impairment is often permanent, since the cut nerve fibres do not grow back. The lack of regeneration has been attributed to a blockage from scar tissue that forms at the lesion. It has therefore been suggested that the nerve fibres could regenerate and that recovery could improve if scar formation is inhibited, and many proposed therapeutic strategies have been designed around this concept. In the present study, the researchers focused on spinal cord stem cells, which are one of the main sources of the scar tissue that is formed after spinal cord injury. They found that when blocking scar formation by preventing the stem cells from forming new cells after an injury, the injury gradually expanded, and more nerve fibres were severed. They also observed that more spinal cord nerve cells died in these mice compared to mice with intact stem cell function, which were able to form normal scar tissue. ”It turned out that scarring from stem cells was necessary for stabilising the injury and preventing it from spreading,” says principal investigator Professor Jonas Frisén at the Department of Cell and Molecular Biology. ”Scar tissue also facilitated the survival of damaged nerve cells. Our results suggest that more rather than less stem cell scarring could limit the consequences of a spinal cord injury.” According to earlier animal studies, recovery can be improved by transplanting stem cells to the injured spinal cord. The new findings suggest that stimulating the spinal cord's own stem cells could offer an alternative to cell transplantation. The study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Tobias Foundation, AFA Insurance, the Strategic Research Programme in Stem Cell Research and Regenerative Medicine (StratRegen) at Karolinska Institutet and the Knut and Alice Wallenberg Foundation.
Publication: 'Resident Neural Stem Cells Restrict Tissue Damage and Neuronal Loss After Spinal Cord Injury in Mice', Hanna Sabelström, Moa Stenudd, Pedro Réu, David O. Dias, Marta Elfineh, Sofia Zdunek, Peter Damberg, Christian Göritz, Jonas Frisén, Sciencex, online 1 November 2013.
Video material of broadcast quality available, please contact the Press Office of Karolinska Instiutet on +46 (0)8-524 860 77 or pressinfo@ki.se. To download portrait images and an animation go to ki.se/pressroom
Contacts
For further information on the study, please contact:
Hanna Sabelström, Doctoral Student
Department of Cell and Molecular Biology
Tel: +46 (0)8-524 872 71
Mobile: +46 (0)707-574 907
Email: hanna.sabelstrom@ki.se
Moa Stenudd, Doctoral Student
Department of Cell and Molecular Biology
Tel: +46 (0)8-524 875 62
Mobile: +46 (0)738-408 966
Email: moa.stenudd@ki.se
Professor Jonas Frisén
Department of Cell and Molecular Biology
Email: Jonas.Frisen@ki.se
Karolinska Institutet (http://ki.se/english) is one of the world’s leading medical universities. It accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
Subscribe to releases from Karolinska Institutet - English
Subscribe to all the latest releases from Karolinska Institutet - English by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Karolinska Institutet - English
New method reveals how the brain and inner ear are formed3.4.2025 20:00:00 CEST | Pressmeddelande
Researchers at Karolinska Institutet have developed a method that shows how the nervous system and sensory organs are formed in an embryo. By labelling stem cells with a genetic ‘barcode’, they have been able to follow the cells’ developmental journey and discover how the inner ear is formed in mice. The discovery, published in Science, could provide important insights for future treatment of hearing loss.
Fluoride in drinking water is associated with impaired childhood cognition7.3.2025 15:30:00 CET | Pressmeddelande
Elevated concentrations of fluoride can occur in well water, and in some countries, it is added to drinking water to counteract caries in the population. A study from Karolinska Institutet in Sweden now supports a few previous studies indicating that exposure to fluoride during the fetal stage or early childhood may impair cognition in children. The study is published in the journal Environmental Health Perspectives.
Children with ARFID face increased risk of disease17.2.2025 17:00:00 CET | Pressmeddelande
Children with avoidant restrictive food intake disorder (ARFID) have an elevated risk of developing psychiatric and physical conditions, a new study from Karolinska Institutet published in JAMA Pediatrics reports. The study highlights the importance of early identification to improve care of these children.
Preterm babies receive insufficient pain management27.1.2025 15:29:17 CET | Pressmeddelande
A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey to date of pain in neonatal care, now published in the journal Pain.
New study paves way for immunotherapies tailored for childhood cancers20.1.2025 17:00:00 CET | Pressmeddelande
Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s immune systems react to different kinds of cancer depending on their age. The study, which is published in the journal Cell, reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom